BenQ Medical Technology Corporation (4116.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 2.47B |
| Enterprise value | 2.94B |
| Trailing P/E | 24.74 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.81 |
| Price/book (mrq) | 2.39 |
| Enterprise value/revenue | 0.95 |
| Enterprise value/EBITDA | 7.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.65 |
| 52-week change 3 | -15.68% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 68.00 |
| 52-week low 3 | 54.20 |
| 50-day moving average 3 | 57.80 |
| 200-day moving average 3 | 59.46 |
Share statistics
| Avg vol (3-month) 3 | 88.61k |
| Avg vol (10-day) 3 | 73.1k |
| Shares outstanding 5 | 44.57M |
| Implied shares outstanding 6 | 44.97M |
| Float 8 | N/A |
| % held by insiders 1 | 57.66% |
| % held by institutions 1 | 0.66% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 2.1 |
| Forward annual dividend yield 4 | 3.79% |
| Trailing annual dividend rate 3 | 2.00 |
| Trailing annual dividend yield 3 | 3.61% |
| 5-year average dividend yield 4 | 3.01 |
| Payout ratio 4 | 93.79% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 20 Jun 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 2.52% |
| Operating margin (ttm) | 9.96% |
Management effectiveness
| Return on assets (ttm) | 4.86% |
| Return on equity (ttm) | 8.44% |
Income statement
| Revenue (ttm) | 4.54B |
| Revenue per share (ttm) | 101.94 |
| Quarterly revenue growth (yoy) | 3.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 532.15M |
| Net income avi to common (ttm) | 114.58M |
| Diluted EPS (ttm) | 2.24 |
| Quarterly earnings growth (yoy) | 60.30% |
Balance sheet
| Total cash (mrq) | 1.15B |
| Total cash per share (mrq) | 25.89 |
| Total debt (mrq) | 1.57B |
| Total debt/equity (mrq) | 72.09% |
| Current ratio (mrq) | 1.99 |
| Book value per share (mrq) | 24.68 |
Cash flow statement
| Operating cash flow (ttm) | 442.35M |
| Levered free cash flow (ttm) | 224.2M |
© 2024 Yahoo. All rights reserved.